
Ep 534 Why a "short list" of acquirers may be a trap
Built to Sell Radio
00:00
Go-to-Market: Sales Trials and Net Negative Churn
Andrew details randomized control trials with clients, strong performance, and expansion within portfolios.
Play episode from 22:11
Transcript


